In vitro and bactericidal activities of ABT-492, a novel fluoroquinolone, against Gram-positive and Gram-negative organisms
about
In vitro activity of Ozenoxacin against quinolone-susceptible and quinolone-resistant gram-positive bacteriaIn vitro antibacterial activities of JNJ-Q2, a new broad-spectrum fluoroquinoloneDelafloxacin, a non-zwitterionic fluoroquinolone in Phase III of clinical development: evaluation of its pharmacology, pharmacokinetics, pharmacodynamics and clinical efficacyPostgenomic strategies in antibacterial drug discovery.Investigational antimicrobial agents of 2013.Contrasting effects of acidic pH on the extracellular and intracellular activities of the anti-gram-positive fluoroquinolones moxifloxacin and delafloxacin against Staphylococcus aureus.Delafloxacin: design, development and potential place in therapyComparison of the antibiotic activities of Daptomycin, Vancomycin, and the investigational Fluoroquinolone Delafloxacin against biofilms from Staphylococcus aureus clinical isolates.Delafloxacin for the treatment of respiratory and skin infections.The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.Efficacy of a new fluoroquinolone, JNJ-Q2, in murine models of Staphylococcus aureus and Streptococcus pneumoniae skin, respiratory, and systemic infections.A randomized, double-blind, Phase 2 study to evaluate subjective and objective outcomes in patients with acute bacterial skin and skin structure infections treated with delafloxacin, linezolid or vancomycinIn Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model.Development of novel antibacterial drugs to combat multiple resistant organisms.New treatment options for lower respiratory tract infections.In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014In Vitro Activity of Delafloxacin Tested against Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.What Is Old Is New Again: Delafloxacin, a Modern Fluoroquinolone.Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study.Emerging treatment options for acute bacterial skin and skin structure infections: focus on intravenous delafloxacin.Activity of delafloxacin against methicillin-resistant Staphylococcus aureus: resistance selection and characterization.Delafloxacin: Place in Therapy and Review of Microbiologic, Clinical and Pharmacologic Properties.Baxdela (Delafloxacin): A Novel Fluoroquinolone for the Treatment of Acute Bacterial Skin and Skin Structure Infections
P2860
Q24596296-40DF8BC4-8CBF-4F01-B8EE-49DC23AABFC5Q24629223-97914F58-52F4-4E81-A634-58ACBA8614C1Q26824268-75900108-B084-4B67-90A3-E8131E8EDB69Q33745572-89934FB5-447C-4AD8-9836-692A75EDEC0AQ34375204-D26EA75F-AB60-48D6-916F-322BEA1A1826Q34528916-350CE0B2-B9A4-49F4-A5F0-CA5A1868AA39Q34554381-6BD0E45A-B89E-468C-99D6-F6F8EA9C5094Q34596619-6F807014-9091-42EE-8FC8-4B414599B5FDQ34667588-8764B544-D6BF-4A8F-A42E-4F7087293F7BQ35482558-D62510B4-E856-4DBF-AF3A-3FCA9C5D3D6FQ35598346-B1B42DAF-3920-44B8-9C5B-346305539202Q36551335-28492BAD-9C6D-4771-8350-51208CB1A769Q37120092-1FC07A49-62C2-4051-85A8-52B350C2D592Q38350301-31CC8787-D2A3-41FF-B5BD-4D613E64D1C9Q40111519-848D8CBC-92C6-48C9-AA78-79232ABC4FBFQ40342746-CE8360F9-F1B3-405A-B39F-088627578404Q41194442-0979E346-7125-4E69-A4C0-1849A19F277EQ47736241-5CEFC85D-E960-4247-B25F-03631D1C3684Q50065370-4BB4A244-9E14-4236-9BB1-77673EB06603Q52579373-694ABFE9-A0C9-4BCA-B69B-9F10EBDC948BQ54297668-7FAADEC0-321C-4AE5-987B-23BEB6FEB376Q55252138-1429224A-4E2C-4E28-9246-682AD729D023Q58574331-427012AC-743F-4DBF-9013-17CCB77E81B6
P2860
In vitro and bactericidal activities of ABT-492, a novel fluoroquinolone, against Gram-positive and Gram-negative organisms
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
In vitro and bactericidal acti ...... ve and Gram-negative organisms
@ast
In vitro and bactericidal acti ...... ve and Gram-negative organisms
@en
type
label
In vitro and bactericidal acti ...... ve and Gram-negative organisms
@ast
In vitro and bactericidal acti ...... ve and Gram-negative organisms
@en
prefLabel
In vitro and bactericidal acti ...... ve and Gram-negative organisms
@ast
In vitro and bactericidal acti ...... ve and Gram-negative organisms
@en
P2093
P2860
P1476
In vitro and bactericidal acti ...... ve and Gram-negative organisms
@en
P2093
Erika L Keller
Jennifer B Hoffrage
Laurel S Almer
Virginia D Shortridge
P2860
P304
P356
10.1128/AAC.48.7.2771-2777.2004
P407
P577
2004-07-01T00:00:00Z